PepGB: Facilitating peptide drug discovery via graph neural networks
Peptides offer great biomedical potential and serve as promising drug candidates. Currently, the majority of approved peptide drugs are directly derived from well-explored natural human peptides. It is quite necessary to utilize advanced deep learning techniques to identify novel peptide drugs in the vast, unexplored biochemical space. Despite various in silico methods having been developed to accelerate peptide early drug discovery, existing models face challenges of overfitting and lacking generalizability due to the limited size, imbalanced distribution and inconsistent quality of experimental data. In this study, we propose PepGB, a deep learning framework to facilitate peptide early drug discovery by predicting peptide-protein interactions (PepPIs). Employing graph neural networks, PepGB incorporates a fine-grained perturbation module and a dual-view objective with contrastive learning-based peptide pre-trained representation to predict PepPIs. Through rigorous evaluations, we demonstrated that PepGB greatly outperforms baselines and can accurately identify PepPIs for novel targets and peptide hits, thereby contributing to the target identification and hit discovery processes. Next, we derive an extended version, diPepGB, to tackle the bottleneck of modeling highly imbalanced data prevalent in lead generation and optimization processes. Utilizing directed edges to represent relative binding strength between two peptide nodes, diPepGB achieves superior performance in real-world assays. In summary, our proposed frameworks can serve as potent tools to facilitate peptide early drug discovery.
Code (0)
등록된 구현이 없습니다.
Tasks
Contrastive LearningDrug DiscoverySimilar Papers 제목 키워드 기반
PepBenchmark: A Standardized Benchmark for Peptide Machine Learning
Peptide therapeutics are widely regarded as the "third generation" of drugs, yet progress in peptide Machine Learning (ML) are hindered by the absence of standardized benchmarks. Here we present PepBenchmark, which unifi…
Drug DiscoveryPPFlow: Target-aware Peptide Design with Torsional Flow Matching
Therapeutic peptides have proven to have great pharmaceutical value and potential in recent decades. However, methods of AI-assisted peptide drug discovery are not fully explored. To fill the gap, we propose a target-awa…
Drug DesignDrug DiscoveryChatGPT-powered Conversational Drug Editing Using Retrieval and Domain Feedback
Recent advancements in conversational large language models (LLMs), such as ChatGPT, have demonstrated remarkable promise in various domains, including drug discovery. However, existing works mainly focus on investigatin…
Decision MakingDrug DiscoveryRetrievalRetrosynthesis+1Surface-based Molecular Design with Multi-modal Flow Matching
Therapeutic peptides show promise in targeting previously undruggable binding sites, with recent advancements in deep generative models enabling full-atom peptide co-design for specific protein receptors. However, the cr…
FROGENT: An End-to-End Full-process Drug Design Multi-Agent System
Drug discovery is a complex, multi-step pipeline that remains heavily dependent on manual, experience-driven operations; meanwhile, existing customized artificial intelligence tools are fragmented across web applications…
Drug Discovery